Cargando…
Prognostic Relevance of Survivin in Pancreatic Endocrine Tumors
BACKGROUND: Better prognostic markers are needed for pancreatic endocrine tumors. Survivin is an apoptosis inhibitor that is suggested to have a negative prognostic impact in several tumor types. Contradictory data exist, especially regarding the significance of a nuclear versus cytoplasmic location...
Autores principales: | Ekeblad, Sara, Lejonklou, Margareta Halin, Stålberg, Peter, Skogseid, Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348449/ https://www.ncbi.nlm.nih.gov/pubmed/22089920 http://dx.doi.org/10.1007/s00268-011-1345-7 |
Ejemplares similares
-
MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
por: Li, Su-Chen, et al.
Publicado: (2021) -
Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours
por: Johansson, Térèse A, et al.
Publicado: (2009) -
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018) -
Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1
por: Åkerström, Göran, et al.
Publicado: (2012) -
Pancreatic endocrine tumors
por: Andrén-Sandberg, Åke
Publicado: (2011)